{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P35225",
      "entity_text" : "IL-13",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:7409",
      "entity_text" : "alpha",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Dupilumab is an interleukin (IL) -4 receptor alpha antagonist that subsequently blocks IL-4 and IL-13 signaling.",
  "reading_complete" : "2020-08-05T22:34:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:32:35Z",
  "trigger" : "blocks",
  "evidence" : [ "alpha antagonist that subsequently blocks IL-4 and IL-13" ],
  "pmc_id" : "5826246",
  "score" : 0
}